SeqOne Genomics
FranceEntry
2019
Hold
7yr
Status
Active
Who owns SeqOne Genomics?
SeqOne Genomics is a French Biotech company, currently owned by Merieux Equity Partners since 2022 and 2 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Bpifrance InvestissementBpifrance Investissement · 2019 · VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2019 · present
Bpifrance InvestissementActive
2019 · present(7yr) · Bpifrance Investissement · 2019 · VC
Omnes CapitalActive
2022 · present(4yr) · Omnes Real Tech 1 · 2018 · VC
Merieux Equity PartnersActive
2022 · present(4yr) · Mérieux Innovation 1 · 2014 · VC
More from Bpifrance Investissement
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns SeqOne Genomics?
SeqOne Genomics is currently owned by Merieux Equity Partners, Omnes Capital and 1 other, through Bpifrance Investissement, since 2022.
When did Merieux Equity Partners and 2 others acquire SeqOne Genomics?
Merieux Equity Partners and 2 others acquired SeqOne Genomics in 2022.
Who has owned SeqOne Genomics over time?
SeqOne Genomics has been through 3 private-equity ownership periods: Bpifrance Investissement · via Bpifrance Investissement · since 2019; Merieux Equity Partners · via Mérieux Innovation 1 · since 2022; Omnes Capital · via Omnes Real Tech 1 · since 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue